Clinical Trial Details

EORTC-1537-LYMG

Back to Clinical Trials Database

Very early FDG-PET-response adapted targeted therapy for advanced Hodgkin lymphoma: a single-arm phase II study

Study documentation

Trial Status Closed to Patient Entry
Dates Date of activation: 30-Jul-2019
Data management at EORTC Yes
Design Phase 2
Not randomized / N.A.
Targeted Sample size EORTC Groups: 150 - All Groups: 150
Treatment Radiotherapy, Drug
Cyclophosphamide, Dacarbazine, Doxorubicin, Etoposide, Vinblastine, Dexamethasone, Brentuximab vedotin
Study Staff Martin Hutchings (Study Coordinator) , Rigshospitalet, Copenhagen
Emanuel Buhrer (Project Physician) , EORTC Headquarters, Brussels
Enrico Clementel (QART Manager) , EORTC Headquarters, Brussels
Shani De Coster (Data Manager) , EORTC Headquarters, Brussels
Terry Desmae (TR Manager) , EORTC Headquarters, Brussels
Ruxandra Dionisie (Pharmacovigilance Manager) , EORTC Headquarters, Brussels
Hazal Erkol (Data Manager) , EORTC Headquarters, Brussels
Catherine Fortpied (Statistician) , EORTC Headquarters, Brussels
Claire Gandilhon (Clinical Operations Assistant) , EORTC Headquarters, Brussels
Hafida Lmalem (Imaging Officer) , EORTC Headquarters, Brussels
Cedric Mallien (Clinical Operations Manager) , EORTC Headquarters, Brussels
Zara Nasir (Pharmacovigilance Manager) , EORTC Headquarters, Brussels
Sarah Nuyens (Project Manager) , EORTC Headquarters, Brussels
Axelle Nzokirantevye (Imaging DM) , EORTC Headquarters, Brussels
Miguel Remis (Lead CRA) , EORTC Headquarters, Brussels
Ward Sents (Clinical Scientist) , EORTC Headquarters, Brussels
Lucy Sepulveda (Regulatory Affairs Administrator) , EORTC Headquarters, Brussels
Maarten Spruyt (Data Manager) , EORTC Headquarters, Brussels
Jelle Stans (Regulatory Affairs Manager) , EORTC Headquarters, Brussels
Bette Stofs (Pharmacovigilance Manager) , EORTC Headquarters, Brussels
Leen Wijnen (Imaging DM) , EORTC Headquarters, Brussels
Gaetan de Schaetzen (Senior Clinical Operations Manager) , EORTC Headquarters, Brussels
Type of cancer Hodgkins Disease
Participating groups EORTC Lymphoma Group
Recruiting centers Amsterdam UMC - Locatie AMC (Amsterdam, Netherlands)
Complejo Hospitalario de Navarra (Pamplona, Spain)
Complejo Hospitalario de Navarra (Pamplona, Spain)
Deventer Ziekenhuis (Deventer, Netherlands)
Erasmus MC (Rotterdam, Netherlands)
Erasmus MC (Rotterdam, Netherlands)
Haaglanden MC - locatie Antoniushove ( Leidschendam, Netherlands)
ICO L’Hospitalet - Hospital Duran i Reynals (Institut Catala D'Oncologia) (L' Hospitalet De Llobregat, Spain)
Instituto Portugues de Oncologia de Lisboa Francisco Gentil – EPE (Lisboa, Portugal)
Maria Sklodowska-Curie National Research Institute of Oncology (Warsaw, Poland)
Maxima Medisch Centrum - Locatie Veldhoven (Veldhoven, Netherlands)
Medisch Centrum Leeuwarden-Zuid (Leeuwarden, Netherlands)
Narodny Onkologicky Ustav - Bratislava (Bratislava, Slovakia)
Radboud University Medical Center Nijmegen (Nijmegen, Netherlands)
Rigshospitalet (Copenhagen, Denmark)
U.Z. Leuven - Campus Gasthuisberg (Leuven, Belgium)
Universitair Ziekenhuis Antwerpen (Edegem, Belgium)
University Medical Center Groningen (Groningen, Netherlands)
ZNA CADIX (Antwerpen, Belgium)
Protocol summary http://clinicaltrials.gov/study/NCT03517137
NCT number NCT03517137
EudraCT 2017-000498-35
Financial Support Educational Grant